Thu, June 24, 2021
Wed, June 23, 2021
Tue, June 22, 2021
Mon, June 21, 2021
Sun, June 20, 2021
Fri, June 18, 2021
Thu, June 17, 2021
Wed, June 16, 2021
Tue, June 15, 2021
Mon, June 14, 2021
Sun, June 13, 2021
Fri, June 11, 2021
Thu, June 10, 2021
Wed, June 9, 2021
Tue, June 8, 2021

Yun Zhong Initiated (SRPT) at Strong Buy and Held Target at $110 on, Jun 15th, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. buy-and-held-target-at-110-on-jun-15th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Yun Zhong of BTIG, Initiated "Sarepta Therapeutics, Inc." (SRPT) at Strong Buy and Held Target at $110 on, Jun 15th, 2021.

Yun has made no other calls on SRPT in the last 4 months.



There are 4 other peers that have a rating on SRPT. Out of the 4 peers that are also analyzing SRPT, 1 agrees with Yun's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $93 on, Monday, April 19th, 2021


These are the ratings of the 3 analyists that currently disagree with Yun


  • Joseph Schwartz of "SVB Leerink" Maintained at Buy with Increased Target to $126 on, Tuesday, March 2nd, 2021
  • Difei Yang of "Mizuho" Maintained at Strong Buy with Increased Target to $160 on, Friday, February 26th, 2021
  • Tazeen Ahmad of "B of A Securities" Maintained at Strong Buy and Held Target at $135 on, Friday, February 26th, 2021

Publication Contributing Sources